Metraipolis › archive › dc_cbcd718782ce

New dimensions of PD-1/PD-L1 inhibitor combination therapy in cancer treatment: current advances and future perspectives — Europe PMC PMID:40936907

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40936907
DOI: 10.3389/fimmu.2025.1616872
License (as archived): solo-consultazione
Archived: 2026-11-10T07:55:51.727Z
SHA-256 of the archived text: 6207498a4333719ce98b044cc5da5ae3d16c3bba1e9d04e2884388e0188ac2f1
Stable URL of this page: https://metraipolis.com/documento/dc_cbcd718782ce

How to cite

New dimensions of PD-1/PD-L1 inhibitor combination therapy in cancer treatment: current advances and future perspectives — Europe PMC PMID:40936907 — Europe PMC (en), https://europepmc.org/article/MED/40936907 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cbcd718782ce (Metraipolis archive dc_cbcd718782ce, sha256 6207498a4333719ce98b044cc5da5ae3d16c3bba1e9d04e2884388e0188ac2f1)

BibTeX

@misc{dccbcd718782ce,
  title = {New dimensions of PD-1/PD-L1 inhibitor combination therapy in cancer treatment: current advances and future perspectives — Europe PMC PMID:40936907},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40936907},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cbcd718782ce; sha256 6207498a4333719ce98b044cc5da5ae3d16c3bba1e9d04e2884388e0188ac2f1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40936907. Agents can read the archived copy with the MCP tool read_document.